Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings
Open Access
- 16 October 2008
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 28 (10) , 1221-1229
Abstract
Summary: Background Faecal calprotectin and lactoferrin increasingly serve as surrogate markers of disease activity in IBD. Data on the correlation of these markers with simple endoscopic score for Crohn’s disease (SES‐CD) and with histological findings are as yet limited.Aim To study the correlation of faecal calprotectin and lactoferrin with SES‐CD and histology.Methods During 87 consecutive ileocolonoscopies, SES‐CD was calculated and biopsy specimens were obtained from the ileum, colon and rectum. Faecal calprotectin and lactoferrin were measured.Results In ileocolonic or colonic disease, both faecal calprotectin and lactoferrin correlated significantly with colon SES‐CD (P < 0.001) and colon histology (P < 0.001). In patients with normal calprotectin or lactoferrin levels, endoscopic and histology scores were significantly lower than in those with elevated concentrations (P < 0.001). In ileal CD, ileal SES‐CD correlated with histology (P < 0.001), but not with faecal calprotectin (P = 0.161) or lactoferrin (P = 0.448).Conclusion In ileocolonic and colonic disease, endoscopic score SES‐CD and histological findings correlated significantly with faecal calprotectin and lactoferrin. A normal faecal‐marker concentration was a reliable surrogate marker for endoscopically and histologically inactive CD. Ileal endoscopic score and histological findings failed, however, to correlate with faecal markers.Keywords
This publication has 38 references indexed in Scilit:
- Accuracy of Four Fecal Assays in the Diagnosis of ColitisDiseases of the Colon & Rectum, 2007
- Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndromeGut, 2007
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- Prospective evaluation of faecal neutrophil‐derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectinAlimentary Pharmacology & Therapeutics, 2007
- Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?Gut, 2007
- Relationship between fecal lactoferrin and inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2007
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Faecal calprotectin in children with chronic gastrointestinal symptomsActa Paediatrica, 2005
- Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2004
- Fecal Lactoferrin Is A Sensitive and Specific Marker in Identifying Intestinal InflammationAmerican Journal of Gastroenterology, 2003